Your browser doesn't support javascript.
loading
Development of pancreatic diseases during long-term follow-up after acute pancreatitis: a post-hoc analysis of a prospective multicenter cohort.
de Rijk, Fem; Sissingh, N J; Boel, T T; Timmerhuis, H C; de Jong, Mjp; Pauw, H S; van Veldhuisen, C L; Hallensleben, N D; Anten, Mpgf; Brink, M A; Curvers, W L; van Duijvendijk, P; Hazen, W L; Kuiken, S D; Poen, A C; Quispel, R; Römkens, Teh; Spanier, Bwm; Tan, Acitl; Vleggaar, F P; Voorburg, Amcj; Witteman, Bjm; Ali, U Ahmed; Issa, Y; Bouwense, Saw; Voermans, R P; van Wanrooij, Rlj; Stommel, Mwj; van Hooft, J E; de Jonge, P J; van Goor, H; Boermeester, M A; Besselink, M G; Bruno, M J; Verdonk, R C; van Santvoort, H C.
Afiliação
  • de Rijk F; Department of Research and Development, St. Antonius Hospital, Nieuwegein, The Netherlands.
  • Sissingh NJ; Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Boel TT; Department of Research and Development, St. Antonius Hospital, Nieuwegein, The Netherlands.
  • Timmerhuis HC; Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands.
  • de Jong M; Department of Research and Development, St. Antonius Hospital, Nieuwegein, The Netherlands.
  • Pauw HS; Department of Research and Development, St. Antonius Hospital, Nieuwegein, The Netherlands.
  • van Veldhuisen CL; Department of Surgery, St. Antonius Hospital, Nieuwegein, The Netherlands.
  • Hallensleben ND; Department of Research and Development, St. Antonius Hospital, Nieuwegein, The Netherlands.
  • Anten M; Department of Gastroenterology and Hepatology, Radboudumc, Nijmegen, The Netherlands.
  • Brink MA; Department of Research and Development, St. Antonius Hospital, Nieuwegein, The Netherlands.
  • Curvers WL; Department of Surgery, St. Antonius Hospital, Nieuwegein, The Netherlands.
  • van Duijvendijk P; Department of Research and Development, St. Antonius Hospital, Nieuwegein, The Netherlands.
  • Hazen WL; Department of Surgery, Amsterdam UMC, location University of Amsterdam, Amsterdam, The Netherlands.
  • Kuiken SD; Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam, The Netherlands.
  • Poen AC; Department of Research and Development, St. Antonius Hospital, Nieuwegein, The Netherlands.
  • Quispel R; Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Römkens T; Department of Gastroenterology and Hepatology, Sint Franciscus Hospital, Rotterdam, The Netherlands.
  • Spanier B; Department of Gastroenterology and Hepatology, Meander Medical Center, Amersfoort, The Netherlands.
  • Tan A; Department of Gastroenterology and Hepatology, Catharina Hospital, Eindhoven, The Netherlands.
  • Vleggaar FP; Department of Surgery, Gelre Hospital, Apeldoorn, The Netherlands.
  • Voorburg A; Department of Gastroenterology and Hepatology, Elisabeth TweeSteden Hospital, Tilburg, The Netherlands.
  • Witteman B; Department of Gastroenterology and Hepatology, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands.
  • Ali UA; Department of Gastroenterology and Hepatology, Isala Clinics, Zwolle, The Netherlands.
  • Issa Y; Department of Gastroenterology and Hepatology, Reinier de Graaf Hospital, Delft, The Netherlands.
  • Bouwense S; Department of Gastroenterology and Hepatology, Jeroen Bosch Hospital, Den Bosch, The Netherlands.
  • Voermans RP; Department of Gastroenterology and Hepatology, Rijnstate Hospital, Arnhem, The Netherlands.
  • van Wanrooij R; Department of Gastroenterology and Hepatology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands.
  • Stommel M; Department of Gastroenterology and Hepatology, University Medical Center, Utrecht, The Netherlands.
  • van Hooft JE; Department of Gastroenterology and Hepatology, Diakonessenhuis, Utrecht, The Netherlands.
  • de Jonge PJ; Department of Gastroenterology and Hepatology, Gelderse Vallei Hospital, Ede, The Netherlands.
  • van Goor H; Department of Surgery, Division of Colorectal Surgery, Columbia University Irving Medical Center-New York Presbyterian Hospital, New York, New York, USA.
  • Boermeester MA; Department of Surgery, Amsterdam UMC, location University of Amsterdam, Amsterdam, The Netherlands.
  • Besselink MG; Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam, The Netherlands.
  • Bruno MJ; Department of Surgery, Maastricht University Medical Center+, Maastricht, The Netherlands.
  • Verdonk RC; Department of Nutrition and Movement Sciences, School of Nutrition and Translational Research in Metabolism (NUTRIM), Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, the Netherlands.
  • van Santvoort HC; Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
J Gastroenterol Hepatol ; 39(4): 674-684, 2024 Apr.
Article em En | MEDLINE | ID: mdl-38191176
ABSTRACT
BACKGROUND AND

AIM:

More insight into the incidence of and factors associated with progression following a first episode of acute pancreatitis (AP) would offer opportunities for improvements in disease management and patient counseling.

METHODS:

A long-term post hoc analysis of a prospective cohort of patients with AP (2008-2015) was performed. Primary endpoints were recurrent acute pancreatitis (RAP), chronic pancreatitis (CP), and pancreatic cancer. Cumulative incidence calculations and risk analyses were performed.

RESULTS:

Overall, 1184 patients with a median follow-up of 9 years (IQR 7-11) were included. RAP and CP occurred in 301 patients (25%) and 72 patients (6%), with the highest incidences observed for alcoholic pancreatitis (40% and 22%). Pancreatic cancer was diagnosed in 14 patients (1%). Predictive factors for RAP were alcoholic and idiopathic pancreatitis (OR 2.70, 95% CI 1.51-4.82 and OR 2.06, 95% CI 1.40-3.02), and no pancreatic interventions (OR 1.82, 95% CI 1.10-3.01). Non-biliary etiology (alcohol OR 5.24, 95% CI 1.94-14.16, idiopathic OR 4.57, 95% CI 2.05-10.16, and other OR 2.97, 95% CI 1.11-7.94), RAP (OR 4.93, 95% CI 2.84-8.58), prior pancreatic interventions (OR 3.10, 95% CI 1.20-8.02), smoking (OR 2.33, 95% CI 1.14-4.78), and male sex (OR 2.06, 95% CI 1.05-4.05) were independently associated with CP.

CONCLUSION:

Disease progression was observed in a quarter of pancreatitis patients. We identified several risk factors that may be helpful to devise personalized strategies with the intention to reduce the impact of disease progression in patients with AP.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pancreatopatias / Neoplasias Pancreáticas / Pancreatite Crônica Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pancreatopatias / Neoplasias Pancreáticas / Pancreatite Crônica Idioma: En Ano de publicação: 2024 Tipo de documento: Article